Home / Business and Economy / Kimberly-Clark Buys Kenvue in $40B Deal, Forming Consumer Brands Giant
Kimberly-Clark Buys Kenvue in $40B Deal, Forming Consumer Brands Giant
3 Nov
Summary
- Kimberly-Clark to acquire Kenvue, maker of Tylenol, for over $40B
- Merger combines iconic brands like Huggies, Kleenex, and Band-Aid
- Kenvue stock surges 20% while Kimberly-Clark drops 16% on the news
On November 3rd, 2025, Kimberly-Clark, the consumer goods giant, announced plans to acquire Kenvue, the maker of Tylenol and other popular consumer health brands, in a deal worth over $40 billion. The cash-and-stock transaction will combine household names like Huggies, Kleenex, Listerine, Neutrogena, and Band-Aid under one company, creating one of the largest global consumer product conglomerates.
The merger values each Kenvue share at $21.01, with $3.50 in cash and 0.14625 shares of Kimberly-Clark stock. The total deal is estimated at around $40.3 billion, with an enterprise value of $48.7 billion. Following the announcement, Kenvue's stock price jumped nearly 20% in premarket trading, while Kimberly-Clark's shares dropped approximately 16%.
Once the transaction is completed, which is expected in the second half of 2026 pending regulatory approvals and shareholder votes, Kimberly-Clark CEO Michael Hsu will become the chairman and CEO of the combined company. The new entity is projected to generate annual revenue of about $32 billion, with Kimberly-Clark shareholders owning 54% and Kenvue shareholders holding the remaining 46%.
